Paediatric and neonatal testing kits sales will strengthen through 2036, anchored by assay kits and reagents at 59% of the product segment in 2026. The market was valued at USD 3.98 billion in 2025 and is expected to be worth USD 7.72 billion by 2036, creating an incremental opportunity of USD 3.49 billion.